DAM
SCLN

DLD Asset Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

DLD Asset Management’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-27,500
Closed -$308K – 124
2017
Q3 		$308K Buy
27,500
+10,200
+59% +$113K 0.03% 77
2017
Q2 		$190K Buy
+17,300
New +$173K 0.02% 82

DLD Asset Management's SCLN Position: Q4 2017 in Review

DLD Asset Management sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 27,500 shares — an estimated $308K sold.

DLD Asset Management first reported a position in SCLN in Q2 2017 and held it in 2 quarters. The position peaked at $308K in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • DLD Asset Management reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • DLD Asset Management sold 27,500 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $308K.
  • DLD Asset Management first reported a position in Sciclone Pharmaceuticals Inc in Q2 2017 and held it in 2 quarters.
  • DLD Asset Management's Sciclone Pharmaceuticals Inc position peaked at $308K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on DLD Asset Management's 13F filing for Q4 2017, filed 12 Feb 2018.